ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 173905 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 173905; 2) Community: the network communities that were significantly associated with the response to NSC 173905; 3) Molecule: the relationships between components within communities and NSC 173905; 4) MDR: the compounds that were significantly associated with the NSC 173905.

NSC Compound Enrichment Correlation
NSC 710895 3-[(1H-Indol-3-ylethyl)amino]-2-(3-isopropoxyphenyl)-2H-pyrido[4,3-e]-1,2,4,-thiadiazine 1,1-dioxide 0.0342636096654271 0.49556634
NSC 716951 Null 0.0342636096654271 0.3573484
NSC 720299 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane 0.0342636096654271 0.1719612
NSC 721049 7Z-Plakortide H 0.0342636096654271 0.22965661
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0342636096654271 0.48845416
NSC 736041 7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne 0.0342636096654271 0.29608703
NSC 737231 Null 0.0342636096654271 0.59003225
NSC 740 Methotrexate 0.0342636096654271 0.24991949
NSC 740476 Null 0.0342636096654271 0.43377288
NSC 743530 Null 0.0342636096654271 0.51554991
Total:116  Current:93    [First] [Prev] [Next] [Last]